MarketInOut Stock Screener Log In | Sign Up

Vaxxinity Inc

OTC • Healthcare • Biotechnology • Quote as of 11/16/2026 14:19
Vaxxinity Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeOTC
Market Capitalization0.0127 mln
Float113 mln
Earnings Date08/03/2026

Relative Strength

71 / 100
Outperforming

Debt / Equity

1.13
Elevated leverage

ROE

-151
Deeply negative

ROA

-48.34
Deeply negative

Business Description

Vaxxinity Inc. is a US-based biotechnology company founded in 2021 and headquartered in Merritt Island, Florida, that develops medicines targeting serious conditions including Alzheimer's disease, Parkinson's disease, high cholesterol, migraines, and COVID-19. The company has several treatments at various stages of clinical testing, ranging from early-phase trials to a late-stage COVID-19 vaccine candidate. Its approach centers on training the body's immune system to neutralize harmful proteins linked to these diseases.

Key Fundamentals

EPS-0.45
ROE-151
ROIC-204
ROA-48.34
Interest Cover-83.74
EBITDA, mln-56.05
EV / EBITDA0.28

Quote Details

Last 0.0001
Change 0 (0%)
Open 0.0001
Volume 1,502
Turnover 0.1502
Average Volume 22,095

Financial Ratios

Leverage Ratio3.30
Current Ratio1.89
Price / Book0.00
Debt / Equity1.13

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -99.6% 0 / 100   
1 Month -99.33% 0 / 100   
2 Months -99.25% 0 / 100   
6 Months -90% 3 / 100   
1 Year -99.33% 2 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog